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ABSTRACT. In the present study, the gene of phenylalanine 2,3-aminomutase 
from Pantoea agglomerans (PaPAM) was cloned into pET-19b vector and 
used for its expression in competent Escherichia coli cells. The recombinant 
plasmid, PaPAM-pET-19b, was transformed into competent E. coli strain 
BL21(DE3)pLysS cells. Overnight culture of the transformed bacteria was 
induced by the addition of isopropylthio-β-D-galactoside (IPTG) to the final 
concentrations of 0.1, 0.5 and 1 mM. Also, the effects of different temperatures 
(18, 25 and 30°C) and the incubation time of PaPAM were examined. The 
fermentation process was scaled up to 10 L fermentor. Affinity purification 
conditions were analyzed by SDS-PAGE. The Tm and the activity of the 
purified enzyme was also investigated. 
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INTRODUCTION 
 
Over the past decades, the preparation of optically pure α-amino 
and β-amino acids has received increasing attention because they have  
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many applications in their free form and as fundamental building blocks of 
bioactive natural products[1]. 
An attractive alternative enzymatic route to obtain enantiomerically 
pure α- and β-amino acids involves the use of phenylalanine ammonia-lyases 
(PALs) and phenylalanine 2,3-aminomutases (PAMs) [2]. 
Phenylalanine ammonia-lyases and 2,3-aminomutases are emerging 
as important enzymatic systems, not only in green synthetic routes to chiral 
amines, but also as potential target for treating diseases such as phenylketonuria 
and cancer [2].  
PAL catalyzes the nonoxidative elimination of ammonia from  
L-phenylalanine to give trans-cinnamic acid, whereas PAM catalyzes the 
isomerization of α- into β-phenylalanine [3]. 
PAMs and PALs are members of the class I lyase-like family that 
includes tyrosine 2,3-aminomutases (TAMs) [4], tyrosine ammonia-lyases 
(TALs)[5], and histidine ammonia-lyases (HALs) [6]. All these enzymes rely 
on a protein-derived cofactor, 4-methylideneimidazol-5-one (MIO), which is 
generated autocatalytically from three active site residues, Ala-Ser-Gly (Thr-
Ser-Gly in PaPAM), forming a MIO signature motif [7,8]. 
The reactions catalyzed by these enzymes have considerable potential 
for biotechnological applications. They are used as biocatalysts for the synthesis 
of (S)-α-amino acids from arylacrylates (PALs), in kinetic resolution processes 
for obtaining (R)-α-amino acids starting from their racemates (PALs), or for 
the synthesis of (R)- or (S)-β-amino acids (TcPAM and PaPAM respectively) 
[9,10, 11,12,13]. 
Further, although TcPAM and PaPAM are both aryl amino acid 2,3-
aminomutases and share the same cofactor dependency and similarity 
(26.7% identity and 42% similarity)[14], they catalyze the α-β-isomerization 
with different stereochemistry. TcPAM catalyzes the isomerization of (S)-α-
amino acids to (R)-β-amino acids, whereas PaPAM converts (S)-α-amino 
acids to (S)-β-amino acids. In this way, both (R) and (S) enantiomers can 
be obtained in enantiomerically pure form. 
TcPAM has been widely used as biocatalyst for synthetic procedures 
related to β-amino acids but the use of PaPAM as biocatalyst is not so 
frequently reported. In the consciousness of this fact, the aim of this work is to 
develop methods for recombinant production of phenylalanine 2,3-aminomutase 
from Pantoea agglomerans (PaPAM) by optimization and scaling up the 
expression process for high level protein expression, in order to obtain PaPAM 
efficient biocatalyst for the preparation of enantiomerically pure (S)-β-amino 
acids. 
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RESULTS AND DISCUSSION 
 Optimization of PaPAM overexpression in E. coli 
E. coli is still the preferred host for recombinant protein expression 
because it is easy to genetically manipulate, it is inexpensive to culture, and 
expression occurs fast [15]. pET system also has many advantages that 
determine us to use it for the expression of our gene. pET is one of the most 
powerful systems developed for the expression of recombinant proteins in E. 
coli [16]. E. coli strain BL21(DE3)pLysS is also the most widely used host for 
recombinant gene expression.[17] Therefore, E. coli was selected as host for 
expression of PaPAM. The aim of this investigation was to examine the effect 
of different experimental conditions on the expression of PaPAM in order to 
obtain high purity and yields for the enzyme which can be used as biocatalyst. 
Inducer concentration optimization 
Varying the concentration of IPTG, expression of proteins can be 
regulated at different levels, lower level expression can increase the solubility 
and activity of the target proteins [18]. With some proteins, it is important to induce 
the transcription of the expression plasmid with lower IPTG concentrations, while 
others tend to aggregate at high concentrations of IPTG [18]. 
For the optimization of PaPAM expression, the effect of different 
concentrations of inducer (0.1, 0.5 and 1 mM IPTG) was tested on the growing 
culture of BL21(DE3)pLysS containing the pET-19b-PaPAM recombinant 
plasmid. The SDS-PAGE bands are similar for 0.5 and 1 mM IPTG concentrations 
(Figure 1, Lane C and D), indicating the same level of expression of the 72 kDa 
PaPAM, despite the increasing inducer concentration. Only a slight difference 
can be observed at 0.1 mM IPTG. (Figure 1, Lane B), showing the most 
intensive signal at the 72 kDa band of the recombinant PaPAM. Based on these 
results, the final concentration of IPTG was set up to 0.1 mM. 
Effect of incubation temperature and time on the overexpression of PaPAM 
The recombinant plasmid pET-19b-PaPAM was overexpressed to 
produce the target protein with an N-terminal His10 tag in E. coli BL21(DE3)pLysS. 
Generally, the optimum temperature for the recombinant protein production in 
E.coli is 37°C and several studies reported 37°C as the best temperature for 
maximum protein production [19]. On the other hand, studies showed that the 
rate of expression and culture temperature can affect the proper folding of 
recombinant proteins and formation inclusion bodies.[20] Lowering the expression 
temperature usually leads to slower growth of bacteria, slower rate of protein 
production and lower aggregation of target protein and also most proteases 
are less active at lower temperatures [21,22]. 
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Figure 1. Induction of the expression of PaPAM by different concentrations of IPTG 
in E.coli BL21(DE3)pLysS cells, after 4h. Lane A: protein ladder, Lane B: induction with 
0.1 mM IPTG, Lane C: induction with 0.5 mM IPTG, Lane D: induction with 1 mM IPTG, 
Lane E: control (0 mM IPTG). The samples were prepared as described in 
experimental section. 
 
To evaluate the effect of growth temperature on the expression of 
PaPAM after induction, the cultures were incubated at different temperatures 
(18, 25, and 37°C). Initially the cell cultures were incubated at 37°C. After the 
density of cells reached OD600 ~0.6 (approx. 4 h) the temperature was reduced 
(to 18 or 25°C) and the cultures were induced with 0.1 mM IPTG. The density 
of the cells was monitored in time (Graphic 1.). 
 
 
 
Graphic 1. Effect of growth temperature on the expression of PaPAM 
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Due to the reduced incubation temperature the protein synthesis rate is 
slower at 18°C than at 25 or 37°C, longer induction times are necessary for 
cells growing. At higher incubation temperature (25 or 37°C), the protein 
synthesis is faster and the stationary phase is reached sooner than at lower 
temperatures. After 20 h the cells were harvested by centrifugation, followed 
by sonication and the protein was purified by metal affinity chromatography on 
Ni-NTA resin. The maximum yield of enzyme was obtained in case of 25°C 
incubation temperature. The optimal post-induction time on the expression of 
PaPAM was 15-16 hours. The determined optimal conditions were also been 
used for the large-scale fermentation of E. coli BL21(DE3)pLysS. 
Purification using Ni-NTA chromatography 
Ni–NTA chromatography system is a rapid and easy purification 
technique. Proteins fused with His-tag at either ends (N- or C-terminus) 
bind tightly with high affinity on immobilized nickel ions. The strong binding 
between His-tag and matrix allows easy washing and efficient elution of 
bounded His-tagged protein by competition with imidazole [23]. 
In the pET-19b vector a His10-tag at the N-terminus is included which is 
longer than the usual His6-tag. Lengthening the His-tag increases the affinity of 
the enzyme to the Ni-NTA resin. Consequently, higher imidazole concentrations 
are required to elute all the bounded enzyme from the resin (from 250 mM up 
to 500 mM) [24]. Accordingly, as the SDS-PAGE gel analysis revealed, only 
small amount of protein remained in the flow through (Figure 2, Lane D) and in 
the washing buffer solutions (Figure 2, Lane E-G).  
 
 
 
Figure 2. Purification of PaPAM with Ni-NTA, in absence of protease inhibitor cocktail. 
Lane A: protein ladder, Lane B: supernatant, Lane C:pellet, Lane D: flow through 
Lane E: LS1, Lane F: HS, Lane G:LS2, Lane H: 20 mM Imidazole, Lane I:  
500 mM Imidazole, Lane J: 1 mM Imidazole. The samples were prepared  
as described in experimental section. 
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It has been observed that PaPAM activity descreased after elution 
from the Ni-NTA column probably due to prolonged exposure to very high 
imidazole concentration and we also observed that the obtained enzyme 
has some unspecific bands on the SDS-PAGE gel (Figure 2, Lane I) due to 
the protease activity for the enzyme. In order to eliminate these facts we 
added protease inhibitor cocktail to the lysis buffer and we reduced de 
imidazole concentration, testing 250, 350, 450, 500 mM imidazole solutions 
for protein elution. The best result was obtained by elution with 350 mM 
imidazole, resulting in protein solution appearing as single band on the 
SDS-PAGE (Figure 3, Lane I), indicating a highly purified enzyme.  
Thermal stability 
Thermal shift (ThermoFluor) assays offer a rapid and simple technique 
for assessing the thermal stability of proteins and to investigate factors 
affecting this stability. An environmentally sensitive fluorescent dye is used to 
monitor protein unfolding with respect to temperature [25]. In the ideal case, 
no fluorescence is observed at low temperature because the protein is 
completely and correctly folded and no hydrophobic areas are exposed. 
Upon an increase in temperature the protein starts to unfold and hydrophobic 
areas become exposed and the fluorescent dye can bind to these areas and 
fluorescence occurs. 
 
 
 
Figure 3. Purification of PaPAM with Ni-NTA, in presence of protease inhibitor cocktail. 
Lane A: protein ladder, Lane B: supernatant, Lane C: flow through, Lane D: pellet, Lane E: 
LS1, Lane F: HS, Lane G:LS2, Lane H: 20 mM Imidazole, Lane I: 350 mM Imidazole, Lane 
J: 1 mM Imidazole. The samples were prepared as described in experimental section. 
The PaPAM enzyme presents a good thermal stability, it can be observed 
in Figure 4 that its maximum melting temperature is approximately 73C.  
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Figure 4. The first derivative of the melt curves. 
 
We also investigated if the substrate of the enzyme has a stabilizing 
effect. Therefore following measurements were performed in TRIS buffer 
solution, pH 8.5 in the presence of L-phenylalanine.  
The melting temperature was read from the negative curve of the 
first derivative of the experimental curve. By comparing the results of the 
measurements obtained in presence and in absence of the substrate, it can 
be observed that the modification of melting temperature in presence of  
L-phenylalanine is minor (from 73C to 74C), suggesting no stability increase 
of the enzyme upon substrate binding. 
Activity assay 
In nature, phenylalanine 2,3-aminonutase from Pantoea agglomerans is an 
(S)-selective enzyme, transforming the (S)-α-phenylalanine in (S)-β-phenylalanine [8]. 
The activity and the selectivity of PaPAM was tested using rac-α-
phenylalanine as substrate (Scheme 1). HPLC analysis of the reaction supports 
the formations of the (S)-β-phenylalanine (Figure 5B) with maximum selectivity 
(compared to the racemic mixture, Figure 5A). 
 
Scheme 1. Transformation of the rac-α-phenylalanine by PaPAM. 
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Figure 5. HPLC chromatograms for: A. rac-β-phenylalanine as control.  
B. Transformation of rac-α-phenylalanine by PaPAM. 
 
 
CONCLUSIONS 
 
We examined different experimental conditions regarding the expression 
and purification of PaPAM in order to obtain high purity and yield for the enzyme. 
IPTG concentrations, various post-induction temperatures on the expression, 
the imidazole concentration in the purification steps, the thermal stability and 
the activity of the enzyme were also examined. 
The results showed that induction with 0.1 M IPTG was sufficient to 
induce the expression of PaPAM, which is 10 times less than normally used 
IPTG concentration. Moreover, 15 hour post-induction incubation at 25°C was 
found to be optimal for producing a higher level of PaPAM. Reducing the 
imidazole concentration to 350 mM and adding protease inhibitor cocktail 
improved the stability of the yielding enzyme. Furthermore, electrophoretically 
pure recombinant PaPAM enzyme preparation was obtained using Ni affinity 
chromatography.  
The detemined optimized parameters were also successfully applied 
for large scale fermentation of PaPAM, obtaining high levels of protein. 
 
 
EXPERIMENTAL SECTION 
PaPAM gene synthesis and cloning 
The gene of the Pantoea agglomerans PAM (Uniprot code: Q84FL5, 
PBD code: 3UNV, encoding 623 AA – Figure 6) was optimized to the codone 
usage of E. coli. The 1639 bps long synthetic gene was produced by Life 
A. 
B. 
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Tehnologies. The gene was cloned into pET-19b host vector using XhoI and 
Bpu1102I cloning site (Figure 7). The pET-19b vector in which the PaPAM 
gene was cloned contains a His10-tag N-terminal sequence, an enterokinase 
cleavage site, a gene resistant to ampicillin and the T7lac promoter sequence. 
In the supplementation of the growth medium ampicillin was replaced by 
carbenicillin, due to the highest stability of later.  
 
 wt-PaPAM 
MSIVNESGSQPVVSRDETLSQIERTSFHISSGKDISLEEIARAARDHQPV 
TLHDEVVNRVTRSRSILESMVSDERVIYGVNTSMGGFVNYIVPIAKASEL 
QNNLINAVATNVGKYFDDTTVRATMLARIVSLSRGNSAISIVNFKKLIEI 
YNQGIVPCIPEKGSLGTSGDLGPLAAIALVCTGQWKARYQGEQMSGAMAL 
EKAGISPMELSFKEGLALINGTSAMVGLGVLLYDEVKRLFDTYLTVTSLS 
IEGLHGKTKPFEPAVHRMKPHQGQLEVATTIWETLADSSLAVNEHEVEKL 
IAEEMDGLVKASNHQIEDAYSIRCTPQILGPVADTLKNIKQTLTNELNSS 
NDNPLIDQTTEEVFHNGHFHGQYVSMAMDHLNIALVTMMNLANRRIDRFM 
DKSNSNGLPPFLCAENAGLRLGLMGGQFMTASITAESRASCMPMSIQSLS 
TTGDFQDIVSFGLVAARRVREQLKNLKYVFSFELLCACQAVDIRGTAGLS 
KRTRALYDKTRTLVPYLEEDKTISDYIESIAQTVLTKNSDI 
 
Figure 6. Amino acids sequence of recombinant wt-PaPAM. 
 
 
Figure 7. pET-19b-PaPAM vector map.  
The vector map was generated using Snapgene. 
 Transformation in E.coli host cells 
Transformation of plasmid DNA into E.coli XL1-Blue (for plasmid 
amplification) and BL21(DE3)pLysS (for expression) was performed using 
the heat shock method, inserting the foreign plasmid into bacteria. After 20 min 
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incubation on ice, the mixture of 100 µL chemically competent bacterial cells 
and 2 µL of plasmid DNA was incubated at 42°C for 45 seconds (heat shock) 
and then placed back on ice for 25 min. 200 µL SOC media was added and 
the transformed cells were incubated at 37°C for 1 h. In case of XL1-Blue 
transformation, the transformed bacteria were plated on LB agar-plates 
containing tetracycline (30 μg/mL) and carbenicilin (50 μg/mL). In case of 
BL21(DE3)pLysS transformation, 50 µg/mL carbenicillin and 30 µg/mL 
chloramphenicol were used. Both cultures were then incubated overnight at 
37°C, forming single colonies of bacteria bearing the plasmid encoding the 
recombinant protein. 
 Expression and production of the recombinant PaPAM 
The recombinant PaPAM carrying N-terminal (His)10-tag was overexpressed 
in E.coli host cells (BL21(DE3)pLysS. For the expression step, a colony of the 
transformed plasmid was grown overnight at 37°C in 5 mL of Luria-Bertani (LB) 
medium containing carbenicillin (50 µg/mL) and chloramphenicol (30 µg/mL). 
A 0.5 L of LB medium was inoculated with 1% (v/v) of the overnight culture in 
an Erlenmeyer flask and grown until the measured optical density at 600 nm 
(OD600) reached 0.6-0.7 at 37°C (optimal temperature for E. coli growth) and 
only at the induction phase the temperature was reduced to 18, 25, 37°C and 
the cells were induced by the addition of (0.1, 0.5, 1 mM) IPTG. The culture was 
shaken at 200 rpm for 16 h. 
Large scale fermentation of the recombinant PaPAM 
Ten litres of Luria-Bertani (LB) medium were sterilized at 121°C, 1.2 
bar for 25 min. After sterilization, the media was cooled down to 37°C and 
ampicillin sodium salt was added to the fermentation broth for a final 
concentration of 100 µg/mL. The fermentation media was inoculated with 100 
mL of the overnight seed culture of the E. coli producer strain. The following 
fermentation parameters were set up: temperature at 37°C, agitation 300 rpm, 
overpressure 0.2 bar and bottom air inlet 5 L/min. The pH value of the 
fermentation broth was controlled at pH 7.1±0.1. The dissolved oxygen (DO) 
value was set to a minimum of 30% and was controlled by the stirring speed. 
When the OD600 of the culture reached 0.7±0.1, the temperature was set to 
25°C and the culture was induced with IPTG (0.1 mM final concentration), 
The fermentation broth was harvested after 16 h when the culture reached 
the stationary growth phase. 
Purification of the recombinant PaPAM 
The cells were harvested by centrifugation (25 min, 5000×g) and 
resuspended in 50 mL lysis buffer (150 mM NaCl, 50 mM TRIS pH 7.5,) 
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supplemented with DNAse, RNAse, Lysosyme, 2 mM PMSF and EDTA-
free protease-inhibitor cocktail. Further, the cells were lysed by sonication 
and cell debris was removed by centrifugation (10000 × g, 30 min). 
The proteins were further purified using a Ni-NTA-agarose column 
and washed with different buffer solutions.  
The column was washed: LS (low salt) buffer, pH 7.5 (4-5V; V=resin 
volume), HS (high salt) buffer, pH 7.5 (2V), LS (2-4V), LS with 20 mM 
imidazole, LS with (250, 350, 450, 500 mM) imidazole (protein elution), LS 
with 1 M imidazole (4V), ddH2O (7V) and 20% ethanol (1-2V), the resin was 
stored in 20% ethanol at 4°C. 
The resulting eluate was dialyzed in 50 mM PBS, 4-5h at 4°C. The 
purity of the resulting fractions was verified by SDS-PAGE analysis. The 
samples were boiled for 5 min in Laemmli buffer and were loaded on a 12% 
SDS-PAGE. After dialysis the fractions containing purified protein were 
concentrated by centrifugal ultrafiltration. The concentration of the purified 
protein was determined by Bradford method.  
Optimization parameters 
To determine the optimal IPTG concentration on the recombinant 
protein production, the recombinant clone culture was grown to OD600 of about 
0.6-0.7, and induced by adding IPTG to final concentrations of 0.1, 0.5 and 1 
mM. After 4 hours of induction, 1 mL samples were colected, centrifuged and 
the pellet resuspended in 0.5 mL dH2O. The samples were lysed by boiled for 
5 min in Laemmli buffer, and were loaded on a 12% SDS-PAGE. 
To examine the effect of temperature, recombinant protein expression 
was induced by addition of 0.1 mM IPTG at different temperatures (18, 25 and 
37°C). The OD600 was monitored by time, after 20 hours of induction, cells 
were harvested by centrifugation, followed by sonication and the protein was 
purified by Ni-NTA. 
Thermostability assay 
The thermal stability of the enzyme was determined by thermofluor 
measurements using real-time PCR as described earlier [26]. 
The assay was performed using a 96-well iCycler iQ Real Time PCR 
plate. The total reaction volume was 25 µL and the plate was set up on ice. 
20 µL of 0.1M TRIS buffer solution was pipetted into the wells of the plate. 
A 5000 × SYPRO Orange stock solution in DMSO was diluted 1:100 in water 
and 1 µL was added to the 20 µL well solution which contained 1.5 mg/mL 
PaPAM protein. The plates were sealed with Optical Quality Sealing Tape 
and centrifuged at 2000 rpm for 1 min. The plate was heated from 20 to 90°C in 
1°C increments in of iCycler iQ Real Time PCR Detection System. 
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Activity assay 
PaPAM activity was determined by the conversion of (S)-α-Phe to 
(S)-β-Phe. Into the solution of rac-α-phenylalanine (2 mg) in TRIS buffer 
(100 mM, pH 8.0, 2 mL), wt-PaPAM (0.8 mg) was added and the reaction 
mixtures was stirred at room temperature. A 100 µL sample was taken and 
the reaction was stopped by heating for 10 min at 90°C in the presence of a 
small amount of activated charcoal. After filtration, the sample was analyzed 
with high performance liquid chromatography (HPLC), using a Chiralpak 
ZWIX(+) column, and MeOH (50 mM formic acid and 100 mM diethyl amine): 
ACN:H2O 49:49:2 (v/v/v) as eluent, respectively. 
 
ACKNOWLEDGMENTS 
 
AV thanks for the financial support of the Sectorial Operational 
Programme for Human Resources Development 2007-2013, co-financed by 
the European Social Fund, under the project POSDRU/159/1.5/S/137750 - 
“Doctoral and postdoctoral programs - support for increasing research 
competitiveness in the field of exact Sciences”. CP thanks for financial support 
from the Romanian National Authority for Scientific Research, CNCS – 
UEFISCDI (PN-II-IDPCE-2011-3-0799). This work was also supported by the 
Hungarian OTKA Foundation (Project NN-103242), by the New Hungary 
Development Plan (Project TÁMOP-4.2.2.B-10/1–2010–0009), by the Hungarian 
Research and Technology Innovation Fund (KMR 12-1-2012-0140) and by the 
EU COST (Action CM1303 “SysBiocat”). 
 
 
REFERENCES 
 
 
[1] K. Faber, Biotransformations in Organic Chemistry. A Textbook, 6th Edition, 2011. 
[2] B. Wu, W. Szymanski, C.G. Crismaru, B.L. Feringa, D.B. Janssen, in "Enzyme 
Catalysis in Organic Synthesis". Eds. K. Drauz, H. Gröger, O. May, Wiley-VCH 
Verlag GmbH & Co. KGaA, 2012, Vol. 2. 
[3] B. Wu, W. Szymanski, S. de Wildeman, G.J. Poelarends, B.L. Feringa, D.B. Janssen, 
Advanced Synthesis and Catalysis, 2010, 352, 1409. 
[4] M.J. MacDonald, G.B.D. Cunha, Biochemistry and Cell Biology, 2007, 85, 273. 
[5] J.A. Kyndt, T.E. Meyer, M.A. Cusanovich, J.J. Van Beeumen, FEBS Letters, 
2002, 512, 240. 
[6] M. Baedeker, G.E. Schulz, European Journal of Biochemistry, 2002, 269, 1790. 
[7] H.A. Cooke, S.D. Bruner, Biopolymers, 2010, 93, 802. 
[8] S. Strom, U. Wanninayake, N.D. Ratnayake, K.D. Walker and J.H. Geiger, 
Angewandte Chemie, 2012, 124, 2952. 
EXPRESSION AND PURIFICATION OF RECOMBINANT PHENYLALANINE 2,3-AMINOMUTASE … 
 
 
 
19 
 
  [9] C. Paizs, A. Katona, J. Rétey, Chemistry - A European Journal, 2006, 12, 2739. 
[10] C. Paizs, M.I. Toșa, L.C. Bencze, J. Brem, F.D. Irimie, J. Rétey, Heterocycles, 
2010, 82, 1217 
[11] A. Gloge, J. Zon, A. Kővári, L. Poppe, J. Rétey, Chemistry A European Journal, 
2000, 6, 3386. 
[12] K. Klettke, S. Sanyal, W. Mutatu , K.D. Walker, Journal of the American Chemical 
Society, 2007, 129, 6988. 
[13] B. Wu, W. Szymanski, P. Wietzes, S. Wildeman, G.J. Poelarends, B.L. Feringa, 
D.B. Janssen, ChemBioChem, 2009, 10, 338. 
[14] http://www.rcsb.org/pdb/workbench/showPrecalcAlignment.do?action= 
pw_fatcat_flexible&name1=3UNV.A&name2=3NZ4.A 
[15] F. Baneyx, Current Opinion in Biotechnology, 1999, 10, 411. 
[16] R.C. Mierendorf, B.B. Morris, B. Hammer, R.E. Novy, Methods in Molecular 
Medicine, 1998, 13, 257. 
[17] http://www.yrbio.com/bioresource/sites/yrbio.com.bioresource/files/ 
document/vector/226410/c183-001.pdf 
[18] J. Sambrook, D.W. Russell, Molecular Cloning a Laboratory Manual. 3rd Edition, 
New York: Cold Spring Harbor Laboratory Press, 2001. 
[19] H.M. Sadeghi, M. Rabbani, E. Rismani, F. Moazen, F. Khodabakhsh, K. Dormiani 
Y. Khazaei, Research in the Pharmaceutical Science, 2011, 6, 87. 
[20] R.Y. Li, C.Y. Cheng. Journal Bioscience and Bioengineering, 2009, 107, 512. 
[21] A. Vera, N. Gonzalez-Montalban, A. Aris, A. Villaverde, Biotechnology and 
Bioengineering, 2007, 96, 1101. 
[22] J.A. Vasina, F. Baneyx, Protein Expression and Purification 1997, 9, 211. 
[23] J. Crowe, H. Dobeli, R. Gentz, E. Hochuli, D. Stiber, K. Hence, Methods in 
Molecular Biology, 1994, 31, 371. 
[24] T. Tanaka, M. Kubota, K. Samizo, Y. Nakajima, M. Hoshino, T. Kohno, E. 
Wakamatsu, Protein Expression and Purification, 1999, 1, 207. 
[25] M.W. Pantoliano, E.C. Petrella, J.D. Kwasnoski, V.S. Lobanov, J. Myslik, E. 
Graf, T. Carver, E. Asel, B.A. Springer, P. Lane, F.R. Salemme, Journal of 
Biomolecular Screening 2001, 6, 429–440. 
[26] J.E. Nettleship, J. Brown, M.R. Groves, A. Geerlof, Methods in Molecular Biology, 
2008, 426, 299. 

